COLLIER ALAN BRIAN (CEO) purchased 0.2% of their position (55K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $597.00 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$54.50
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$54.50
% of position
Common Stock
Shares
+20K
Price / share
$0.01
Trade value
$218.00
% of position
Common Stock
Shares
+10K
Price / share
$0.01
Trade value
$109.00
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$54.50
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$54.00
% of position
Common Stock
Shares
+5K
Price / share
$0.01
Trade value
$52.50
% of position
Net shares
+55K
Net value
$597.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2019 | P · Purchase | +5K | $0.01 | $54.50 | 0.0% | 25.01M | 25.02M |
| Common Stock Direct | 8/16/2019 | P · Purchase | +5K | $0.01 | $54.50 | 0.0% | 25.02M | 25.02M |
| Common Stock Direct | 8/16/2019 | P · Purchase | +20K | $0.01 | $218.00 | 0.1% | 25.02M | 25.04M |
| Common Stock Direct | 8/16/2019 | P · Purchase | +10K | $0.01 | $109.00 | 0.0% | 25.04M | 25.05M |
| Common Stock Direct | 8/16/2019 | P · Purchase | +5K | $0.01 | $54.50 | 0.0% | 25.05M | 25.06M |
| Common Stock Direct | 8/16/2019 | P · Purchase | +5K | $0.01 | $54.00 | 0.0% | 25.06M | 25.06M |
| Common Stock Direct | 8/19/2019 | P · Purchase | +5K | $0.01 | $52.50 | 0.0% | 25.06M | 25.07M |
| Total | +55K | $597.00 | ||||||